Table 3. Screening and presence of fibromuscular dysplasia.
n=373 | ||
No screening performed | 33 (8.8) | |
Incomplete screening (at least one location screened) | 63 (16.9) | |
Complete screening | 277 (74.3) | |
Screening modality | n=340 | |
Computed tomographic angiography only | 237 (69.7) | |
Magnetic resonance angiography only | 37 (10.9) | |
Angiography during catheterisation only | 7 (2.1) | |
Ultrasound only | 3 (0.8) | |
Multimodal | 56 (16.5) | |
Presence of FMD | n=340 | |
FMD | 153 (45) | |
One localisation | 95 (27.9) | |
Multifocal FMD | 58 (17.1) | |
FMD prevalence and complete screening | n=277 | |
FMD | 131 (47.3) | |
FMD localisation | Carotid | 63/288 (21.9) |
Vertebral | 20/289 (6.9) | |
Renal | 93/330 (28.2) | |
Iliac | 47/325 (14.5) | |
Visceral | 16/263 (6.1) | |
Data are shown as n (%). FMD: fibromuscular dysplasia |